v


Zhengzhou First Affiliated Hospital Successfully Completes 12 SHURUI® Single-Port Surgical Robotic Esophageal Cancer Surgeries — Ushering a New Era in Minimally Invasive Esophageal Cancer Treatment

 

Recently, the thoracic surgery team led by Directors Xiangnan Li and Jia Zhao at Zhengzhou University First Affiliated Hospital achieved a major milestone by performing 12 esophageal cancer radical resections using the SHURUI® single-port surgical robot. This marks a significant breakthrough in minimally invasive esophageal cancer treatment in China.

 

Unlike traditional multi-port robotic systems such as Da Vinci SP, which require multiple incisions and have limited operating range, the SHURUI® system enables a single 3cm intercostal incision with a flexible snake-arm reach of 22cm, covering the entire esophagus and mediastinum without frequent arm repositioning.

 

The innovative sheath design avoids tissue damage caused by instrument-rib friction seen in rigid systems. Average surgery time was approximately 4 hours, nearly 15% faster than comparable procedures using Da Vinci SP.

 

This successful series validates the SHURUI® system’s clinical efficacy and safety, establishing a pioneering “China solution” for esophageal cancer minimally invasive surgery and paving the way for future clinical guidelines and wider adoption.

 

Important Notes

The Single-port Endoscopic Surgical System (SR-ENS-600), developed and produced by Beijing Surgerii Robotics Company Limited, has been approved by the National Medical Products Administration (NMPA) in China for urology and gynecology laparoscopic surgeries. Surgeons who wish to learn the surgical operations of the SHURUI robot should contact Beijing Surgerii Robotics Co., Ltd. to participate in the official training program. Patients who want to participate in the registered clinical trials of the SHURUI robot should contact the official cooperative hospitals of Surgerii and consult with surgeons to determine their suitability for surgery with the SHURUI robot. Both surgeons and patients should carefully understand all information regarding the performance of surgeries by the SHURUI robot and its potential risks.


Beijing Surgerii Robotics Co., Ltd. owns Surgerii®, SHURUI®, and other trademarks and may not be used without permission.